Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
7
×
biotech
boston blog main
boston top stories
7
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
startups
7
×
alzheimer's disease
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
cancer immunotherapy
clinical trials
deals
eli lilly
investing
medicare
novartis
pfizer
abbvie
What
bio
roundup
drug
new
alzheimer’s
ceo
companies
crispr
medicines
price
prices
research
acquisitions
activity
aims
albert
alliance
annual
approval
approvals
assessed
attention
backed
biggest
biogen
biogen’s
biopharmaceutical
biotech
bourla
bristol
buy
calls
cause
changing
clamped
color
communities
company
conference
convo
Language
unset
unknown
Current search:
biogen
×
startups
×
" boston top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More